PT - JOURNAL ARTICLE AU - Nerea Alonso AU - Karol Estrada AU - Omar M E Albagha AU - Lizbeth Herrera AU - Sjur Reppe AU - Ole K Olstad AU - Kaare M Gautvik AU - Niamh M Ryan AU - Kathryn L Evans AU - Carrie M Nielson AU - Yi-Hsiang Hsu AU - Douglas P Kiel AU - George Markozannes AU - Evangelia E Ntzani AU - Evangelos Evangelou AU - Bjarke Feenstra AU - Xueping Liu AU - Mads Melbye AU - Laura Masi AU - Maria Luisa Brandi AU - Philip Riches AU - Anna Daroszewska AU - José Manuel Olmos AU - Carmen Valero AU - Jesús Castillo AU - José A Riancho AU - Lise B Husted AU - Bente L Langdahl AU - Matthew A Brown AU - Emma L Duncan AU - Stephen Kaptoge AU - Kay-Tee Khaw AU - Ricardo Usategui-Martín AU - Javier Del Pino-Montes AU - Rogelio González-Sarmiento AU - Joshua R Lewis AU - Richard L Prince AU - Patrizia D’Amelio AU - Natalia García-Giralt AU - Xavier Nogués AU - Simona Mencej-Bedrac AU - Janja Marc AU - Orit Wolstein AU - John A Eisman AU - Ling Oei AU - Carolina Medina-Gómez AU - Katharina E Schraut AU - Pau Navarro AU - James F Wilson AU - Gail Davies AU - John Starr AU - Ian Deary AU - Toshiko Tanaka AU - Luigi Ferrucci AU - Fernando Gianfrancesco AU - Luigi Gennari AU - Gavin Lucas AU - Roberto Elosua AU - André G Uitterlinden AU - Fernando Rivadeneira AU - Stuart H Ralston TI - Identification of a novel locus on chromosome 2q13, which predisposes to clinical vertebral fractures independently of bone density AID - 10.1136/annrheumdis-2017-212469 DP - 2017 Nov 23 TA - Annals of the Rheumatic Diseases PG - annrheumdis-2017-212469 4099 - http://ard.bmj.com/content/early/2017/11/23/annrheumdis-2017-212469.short 4100 - http://ard.bmj.com/content/early/2017/11/23/annrheumdis-2017-212469.full AB - Objectives To identify genetic determinants of susceptibility to clinical vertebral fractures, which is an important complication of osteoporosis.Methods Here we conduct a genome-wide association study in 1553 postmenopausal women with clinical vertebral fractures and 4340 controls, with a two-stage replication involving 1028 cases and 3762 controls. Potentially causal variants were identified using expression quantitative trait loci (eQTL) data from transiliac bone biopsies and bioinformatic studies.Results A locus tagged by rs10190845 was identified on chromosome 2q13, which was significantly associated with clinical vertebral fracture (P=1.04×10−9) with a large effect size (OR 1.74, 95% CI 1.06 to 2.6). Bioinformatic analysis of this locus identified several potentially functional SNPs that are associated with expression of the positional candidate genes TTL (tubulin tyrosine ligase) and SLC20A1 (solute carrier family 20 member 1). Three other suggestive loci were identified on chromosomes 1p31, 11q12 and 15q11. All these loci were novel and had not previously been associated with bone mineral density or clinical fractures.Conclusion We have identified a novel genetic variant that is associated with clinical vertebral fractures by mechanisms that are independent of BMD. Further studies are now in progress to validate this association and evaluate the underlying mechanism.